
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
hnRNP UL1 CRISPR/Cas9 KO Plasmid (h) | sc-405017 | 20 µg | $397.00 |
HNRNPUL1 encodes the human heterogeneous nuclear ribonucleoprotein UL1, an RNA- and DNA-associated factor that participates in pre-mRNA processing and the coordination of gene expression with genome maintenance. hnRNP UL1 has been linked to DNA damage response programs, including recruitment and regulation of repair-associated complexes at sites of genotoxic stress, thereby influencing replication stress handling and transcription-coupled repair. Through these roles, HNRNPUL1 impacts cellular proliferation and stress adaptation by modulating RNA metabolism and chromatin-associated repair processes. Altered hnRNP UL1 function or expression has been reported in contexts involving genomic instability and dysregulated RNA processing, supporting its relevance in mechanistic studies of disease-associated pathways.
hnRNP UL1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HNRNPUL1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HNRNPUL1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HNRNPUL1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish hnRNP UL1 protein expression.
This CRISPR knockout system enables efficient generation of HNRNPUL1-deficient cell models for investigation of hnRNP UL1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.